Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic D Bushman

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature|December 23, 2011
Global landscape of HIV-human protein complexesStefanie Jäger, Peter Cimermancic, Natali Gulbahce, et al.
The Journal of Clinical Investigation|August 16, 2021
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemiaWeimin Kong, Alexander Dimitri, Wenliang Wang, et al.
Nature Medicine|January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous diseaseDonald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021Andrew D Marques, Scott Sherrill-Mix, John Everett, et al.
Nature|June 1, 2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cellsJoseph A Fraietta, Christopher L Nobles, Morgan A Sammons, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Mbio|February 8, 2022
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021Andrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
Nature Medicine|January 9, 2023
Autologous T cell therapy for MAGE-A4<sup>+</sup> solid cancers in HLA-A*02<sup>+</sup> patients: a phase 1 trialDavid S Hong, Brian A Van Tine, Swethajit Biswas, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature|December 23, 2011
Global landscape of HIV-human protein complexesStefanie Jäger, Peter Cimermancic, Natali Gulbahce, et al.
The Journal of Clinical Investigation|August 16, 2021
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemiaWeimin Kong, Alexander Dimitri, Wenliang Wang, et al.
Nature Medicine|January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous diseaseDonald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021Andrew D Marques, Scott Sherrill-Mix, John Everett, et al.
Nature|June 1, 2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cellsJoseph A Fraietta, Christopher L Nobles, Morgan A Sammons, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Mbio|February 8, 2022
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021Andrew D Marques, Scott Sherrill-Mix, John K Everett, et al.
Nature Medicine|January 9, 2023
Autologous T cell therapy for MAGE-A4<sup>+</sup> solid cancers in HLA-A*02<sup>+</sup> patients: a phase 1 trialDavid S Hong, Brian A Van Tine, Swethajit Biswas, et al.
Pageof 35